Interferon alfa-2a in recurrent metastatic hemangiopericytoma.

نویسندگان

  • Herwig Lackner
  • Christian Urban
  • Hans Jürgen Dornbusch
  • Wolfgang Schwinger
  • Reinhold Kerbl
  • Petra Sovinz
چکیده

1. Webber BL, Parham DM, Drake LG, et al. Renal tumors in childhood. Pathol Ann Part 1992;1:191–232. 2. Murphy WM, Beckwith JB, Farrow GM. Tumors of the kidney, bladder and related urinary structures. In: Murphy WM, Beckwith JB, Farrow GM, editors. Atlas of tumor pathology, series 3, fascicle 11. Washington D.C.: Armed Forces Institute of Pathology, 1994. 3. Beckwith JB. Pediatric neoplastic disorders of the kidney. In: Sternberg SS, editor. Diagnostic surgical pathology. Raven Press; 1994. p 1741–1766. 4. Parham DM. Renal neoplasms. In: Parham DM, editor. Pediatric neoplasia: morphology and biology. Lippincott-Raven; 1996. p 33–64. 5. Charles AK, Vujanic GM, Berry PJ. Renal tumors of childhood. Histopathology 1998;32:293–309. 6. Zuppan CV, Beckwith JB, Luckey DW. Anaplasia in unilateral Wilms tumor: a report from the National Wilms Tumor Study Pathology Center. Hum Pathol 1988;19:1199–1299. 7. Faria P, Beckwith JB, Mishra K, et al. Focal versus diffuse anaplasia in Wilms tumor: new definitions with prognostic significance. A report from the National Wilms Tumor Study Group. Am J Surg Pathol 1996;20:909–920. 8. Argani P, Perlman EJ, Breslow NE, et al. Clear cell sarcoma of the kidney. Am J Surg Pathol 2000;24:4–18. 9. Delemarre JF, Sandstedt B, Harms D, et al. The new SIOP (Stockholm) working classification of renal tumors of childhood. International Society of Paediatric Oncology. Med Pediatr Oncol 1996;26:145– 146. 10. Boccon-Gibod LA. Pathological evaluation of renal tumors in children: International Society of Pediatric Oncology approach. Ped Dev Pathol 1998;1:243–248. 11. Zuppan CW. Handling and evaluation of pediatric renal tumors. Am J Clin Pathol 109:S31–S37. 12. Jenkins MC, Allibone EB, Berry PJ. Neuroglial tissue in partially cystic Wilms tumour. Histopathology 1991;18:309–313. 13. Magee F, Mah RG, Taylor GP, et al. Neural differentiation in Wilms tumor. Hum Pathol 1987;18:33–37. 14. Brough AJ. Mesoblastic nephroma. Pediatr Pathol 1993;13:885–886. 15. Argani P, Beckwith JB. Metanephric stromal tumor. Report of 31 cases of a distinctive pediatric renal neoplasm. Am J Surg Pathol 2000;24:917– 926. 16. Variend S, Spicer RD, McKinnon AE. Teratoid Wilms tumour. Cancer 1984;53:1936–1942. 17. Vujanic GM. Teratoid Wilms Tumor. Pediatr Pathol 1991;11:303–309. 18. Magee JF, Ansari S, McFadden DE, et al. Teratoid Wilms tumour: a report of two cases. Histopathology 1992;20:427–431.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Safety and Efficacy of Pegylated Interferon Alfa-2a for the Treatment of Hepatitis C in Patients with Major Thalassemia

Background: Hepatitis C virus (HCV) infection is the most common transfusion transmitted disease in poly-transfused patients worldwide. In this study we aimed to evaluate the effects of pegylated interferon alfa-2a (PEG-IFN A-2a) in reducing serum ALT and eradicating serum hepatitis C virus (HCV) RNA in HCV infected polytransfused thalassemic patients. Materials and Methods: A cohort of 51 HCV-...

متن کامل

Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial

BACKGROUND In metastatic renal cell carcinoma combinations of interferon alfa-2a, interleukin-2, and fluorouracil produce higher response rates and longer progression-free survival than do single agents. We aimed to compare overall survival in patients receiving combination treatment or interferon alfa-2a. METHODS RE04/30012 was an open-label randomised trial undertaken in 50 centres across e...

متن کامل

Severe muscle weakness during treatment with pegylated interferon alfa for chronic hepatitis C virus infection A rare complication

Background: Interferons (IFNs) are common therapeutics for several diseases such as viral hepatitis, multiple sclerosis and malignancy. A variety of autoimmune related side effects have been observed during IFN therapy. Rare cases of myopathy, polymyositis or dermatomyositis have been reported during therapy with high doses of IFN^5. Case Presentation: In this report, we describe a case with se...

متن کامل

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial.

BACKGROUND Vascular endothelial growth factor (VEGF) inhibition is a valid therapeutic approach in renal cell carcinoma. Therefore, an investigation of the combination treatment of the humanised anti-VEGF monoclonal antibody bevacizumab with interferon alfa was warranted. METHODS In a multicentre, randomised, double-blind, phase III trial, 649 patients with previously untreated metastatic ren...

متن کامل

Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data.

Multicenter randomized trials have shown that once-weekly pegylated interferon (peginterferon) alfa-2a is more efficacious than conventional interferon alfa-2a (IFN) in patients with chronic hepatitis C. We performed a meta-analysis of 1,013 previously untreated patients (from 3 randomized trials) with pretreatment and post-treatment liver biopsies to assess the differences between peginterfero...

متن کامل

Peginterferon alfa-2a plus ribavirin for treating chronic hepatitis C virus infection: analysis of Mexican patients included in a multicenter international clinical trial.

Treatment with polyethylene glycol-modified interferon alfa-2a (peginterferon) alone produces significantly higher sustained antiviral responses than treatment with interferon alfa-2a alone in patients with chronic hepatitis C virus (HCV) infection. We compared the efficacy and safety of peginterferon alfa-2a plus ribavirin, interferon alfa-2b plus ribavirin, and peginterferon alfa-2a alone in ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Medical and pediatric oncology

دوره 40 3  شماره 

صفحات  -

تاریخ انتشار 2003